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Abstract
Background. In the Małopolska province, the first case of vancomycin resistant enterococci (VRE) occurrence 
was an outbreak in 2001 caused by strains of the genus E. faecium carrying the vanA operon.
Objectives. The aim of this study is to determine the antimicrobial resistance and the occurrence of virulence 
determinants among Enterococcus spp. in patients hospitalized in the Małopolska region in 2015.
Material and methods. Antimicrobial susceptibility was determined by disc diffusion and the E test. 
The presence of aminoglycoside and glycopeptide resistance genes and virulence genes (asa1, gelE, cylA, 
esp, hyl) was investigated using multiplex polymerase chain reaction (PCR). Also, the presence of IS16 was 
investigated. The activity of gelatinase, cytolysin (hemolysin), and DNase was tested.
Results. All E. faecalis were susceptible to ampicillin, vancomycin, teicoplanin, linezolid and tigecycline. 
All E. faecium strains were susceptible to quinupristin-dalfopristin. Resistance to ampicillin and vancomycin 
was detected among all E. faecium isolates from hospitals C and D. 87.32% of E. faecium presented high-level 
aminoglycoside-resistant (HLAR) phenotype, including 78.33% of strains from hospital C and 100% from 
hospital D. In hospital C (98.3%) and D (96%), resistance to ciprofloxacin, levofloxacin and norfloxacin was 
observed. Gene esp was detected in all E. faecium isolates and the majority of E. faecium isolates carried 
hyl (97%). In E. faecalis, different combinations of virulence genes were detected. All analyzed E. faecium 
strains showed the presence of IS16 insertion element.
Conclusions. E. faecalis isolates were more susceptible to antimicrobials than E. faecium, which were largely 
multidrug-resistant. E. faecalis strains have diverse virulence factors. E. faecium showed a high percentage 
of hyl and esp genes and the presence of IS16.
Key words: virulence factors, healthcare-associated infections, Enterococcus, vancomycin resistant entero-
cocci (VRE), antimicrobial susceptibility
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Introduction
Enterococci are now recognized as a significant cause 
of healthcare-associated infections worldwide.1–3 The emer-
gence of multidrug resistance (MDR), including high-level 
aminoglycoside-resistant (HLAR) enterococci and vanco-
mycin-resistant enterococci (VRE), causes great difficul-
ties in clinical antimicrobial therapy.4 VRE infections have 
been associated with higher mortality, longer hospital length 
of stay, and higher costs compared with vancomycin-suscep-
tible isolates.5,6 The first vancomycin-resistant E. faecium 
(VREfm) strains carrying the vanA operon and vanB operon 
were reported in Poland in 1996 and 1999, respectively.7 
In the Małopolska province, the first case of VRE occurrence 
was an outbreak caused by strains of the genus E. faecium 
carrying the vanA operon in 2001.8,9 
The aim of this study is to determine the virulence fac-
tors and antibiotic resistance patterns of enterococcal 
isolates from 4 hospitals with different specialties from 
the Małopolska region.
Material and methods
Hospital settings
Pieces of  information were obtained from hospitals 
from which enterococcal strains were isolated, regarding 
ward locations and body sites from which VRE and other 
enterococci were recovered. Material for the study was 
taken according to the following criteria: from patients 
with symptomatic infection as well as from patients admit-
ted from other hospitals, Social Welfare Homes, Health 
Care Centers; patients who had previously been treated 
in another hospital and had been given broad-spectrum 
antibiotics; patients who had information about VRE colo-
nization in their discharge card; the ones who were repeat-
edly hospitalized for 12 months.
Characteristic of Enterococcus strains
In this hospital-based study, a total of 154 Enterococcus 
strains isolated from 4 hospitals during the period from 
January 2015 through December 2015 were collected. Six 
of the samples were collected from hospital A, 13 samples 
were from B, 60 were from C, and 75 samples were acquired 
from hospital D. The enterococcal isolates were obtained 
from different specimens and were classified as coloniza-
tion or infection. The study comprised consecutive, non-
repetitive enterococci isolates.
All strains had already been identified with the spe-
cies level using conventional biochemical tests and with 
the VITEK-2 COMPACT fully automated microbiological 
system in hospital laboratories. The identification was con-
firmed by species-specific multiplex polymerase chain re-
action (PCR) as described by Jackson (E. faecalis – 360 bp, 
E. faecium – 215 bp and E. avium – 368 bp) using the DNA 
samples of each Enterococcus strain isolated by Genomic 
Mini (A&A Biotechnology, Gdynia, Poland).10
Antibiotic susceptibility testing
Susceptibility to antimicrobials was evaluated by the disc-
diffusion method (Oxoid, Basingstoke, England) according 
to manufacturer’s procedure. The minimum inhibitory con-
centrations (MICs) of ampicillin, ciprofloxacin, tigecycline 
and linezolid were evaluated by the E tests method (bioMéri-
eux, Marcy l’Etoile, France) according to the manufacturer’s 
procedure. 
The presence of HLAR phenotype, HLGR (high-level gen-
tamicin resistance) and HLSR (high-level streptomycin resis-
tance) phenotypes were identified by the disk susceptibility 
tests with streptomycin and gentamicin. VRE phenotype 
was detected by teicoplanin and vancomycin. The HLAR 
and VRE phenotypes were confirmed by the E tests method. 
All tests carried out using both methods were done on freshly 
prepared Mueller Hinton II Agar (Biocorp, Warszawa, Po-
land). The interpretation was performed in accordance with 
the recommendations of the European Committe on An-
timicrobial Susceptibility Testing (EUCAST) guidelines.11 
Assay of gelatinase activity
The production of gelatinase in Enterococcus strains 
was detected with  the method described by Strzelecki.12 
Gelatinase activity was observed as a transparent halo 
around the enterococcal colonies.
Detection of antimicrobial resistance genes
To  detect genes responsible for HLAR phenotype 
in the genomes of all the strains resistant to gentamicin 
and/or streptomycin, multiplex PCR was applied according 
to the method of Vakulenko.13 The results of VRE testing 
by the phenotype method were confirmed by investigating 
vanA (732 bp) and vanB (635 bp) operons using the multi-
plex PCR as described by Biendo.14 
Table 1. Characteristics of the studied hospitals 
Hospital
Body sites Units
blood rectal swab others* ICU surgery others**
A 5 0 1 2 0 4
B 0 0 13 2 7 4
C 1 49 10 25 15 20
D 2 55 18 57 7 11
Total 8 104 42 86 29 39
* pleural effusion, cerebrospinal fluid, urine, bronchial aspirates, surgical 
wound; ** Clinical Department of Interventional Cardiology, Department 
of Pulmonary Diseases, Department of Internal Medicine, Department 
of Orthopedic Trauma, Department of Neurology, Stroke Unit, 
Department of Urology; ICU – intensive care unit.
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Detection of virulence factor genes
To detect the presence of genes encoding selected viru-
lence factors (asa1, gelE, cylA, esp, hyl – 375bp, 213 bp, 
688 bp, 510 bp, 276 bp, respectively) in the enterococcal 
DNA, multiplex PCR was applied according to the meth-
ods of Vankerckhoven.15 The presence of quorum-sensing 
genes ( fsrA, fsrB, fsrC) in the genomes of all the strains 
positive for the gelE gene was tested by multiplex PCR and 
was applied pursuant to Qin.16 The product sizes for fsrA, 
fsrB and fsrC were 484 bp, 574 bp and 580 bp, respectively.
Assay of cytolysin (hemolysin) activity
Cytolysin activity in Enterococcus strains was detect-
ed by  the method described by Kowalska-Krochmal.17 
The presence of a clear zone surrounding the studied strain 
colonies indicated the production of cytolysin.
Assay of DNase activity
DNase activity was detected on BD DNase Test Agar 
(Becton Dickinson, Oxford, England) described by Kow-
alska-Krochmal.17 DNase positive organisms will be sur-
rounded by clear zones of depolymerized DNA. Colonies 
of DNase negative organisms will not show any clearing 
around the colonies.
Detection of a specific mobile insertion 
element IS16 by PCR
PCR was performed with primers encoding gene frag-
ment of the insertion sequence IS16.18 The product sizes 
were 547 bp, which is specific for IS16 element.
Results
Hospital settings
Generally, over half of the strains were isolated from 
patients hospitalized in ICU (55.84%), of which the high-
est proportion of enterococci was isolated from patients 
in hospital D and accounted for, respectively, the highest 
percentage (76%) of strains in that hospital and among 
other hospitals.
In hospital A, no strain originated from a patient op-
erated on, while in hospital B, it was the surgical unit 
that was the source of most strains (53.84%). In general, 
most enterococci were isolated from perianal swabs, which 
resulted from a high rate of isolation in hospitals C and D. 
In hospitals A and B, no enterococci were isolated from 
rectal swabs. Only in hospital A, the biggest proportion 
of enterococci was isolated from the blood. At the remain-
ing facilities, enterococci were significantly more often 
isolated from materials other that blood, as there is no pro-
cedure for screening for VRE on admission (Table 1).
Distribution of Enterococcus species 
in various clinical specimens
The highest prevalence of E. faecium was demonstrat-
ed in rectal swabs (75%), followed by wounds (12.5%), 
lower respiratory tract specimens (5.8%), urine (3.7%), 
blood (2.2%), and others (0.8%). The highest prevalence 
of E.  faecalis was detected in wounds (47%), followed 
by blood and lower respiratory tract specimens (23.5% 
each), and cerebrospinal fluid (6%). In our study, only one 
E. avium isolate was detected, and it was found in a post-
operative wound swab.
Table 2. Prevalence of antimicrobial resistance in Enterococcus species isolated from hospitals A, B, C, and D (disk diffusion method)
Antibiotic
Hospital
A B C D
S R S R S R S R
Ampicillin 5 (83.3) 1 (16.7) 8 (61.5) 5 (38.5) 0 (0) 60 (100) 0 (0) 75 (100)
Ciprofloxacin 4 (66.7) 2 (33.3) 6 (46.2) 7 (53.8) 1 (1.7) 59 (98.3) 3 (4) 72 (96)
Levofloxacin 4 (66.7) 2 (33.3) 7 (53.8) 6 (46.2) 2 (1.7) 60 (98.3) 3 (4) 72 (96)
Norfloxacin 4 (66.7) 2 (33.3) 6 (46.2) 7 (53.8) 3 (1.7) 61 (98.3) 3 (4) 72 (96)
Gentamicin 3 (50) 3 (50) 6 (46.2) 7 (53.8) 3 (5) 57 (95) 0 (0) 75 (100)
Streptomycin 6 (100) 0 (0) 8 (61.5) 5 (38.5) 8 (13.3) 52 (86.7) 9 (12) 66 (88)
Vancomycin 6 (100) 0 (0) 12 (92.3) 1 (7.7) 0 (0) 60 (100) 0 (0) 75 (100)
Teicoplanin 6 (100) 0 (0) 12 (92.3) 2 (7.7) 15 (25) 45 (75) 70 (93.3) 5 (6.7)
Tigecycline 6 (100) 0 (0) 13 (100) 0 (0) 60 (100) 0 (0) 75 (100) 0 (0)
Linezolid 6 (100) 0 (0) 13 (100) 0 (0) 60 (100) 0 (0) 75 (100) 0 (0)
Quinupristin-dalfopristin 1*(100) 0 (0) 3*(100) 0 (0) 60*(100) 0 (0) 75*(100) 0 (0)
S – susceptible; R – resistant; n (%) – number (percentage) of strains; * quinupristin-dalfopristin was evaluated for E. faecium only.
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Comparison of antimicrobial resistance 
between E. faecium and E. faecalis and 
antimicrobial resistance in Enterococcus 
species isolated from various hospitals
The E test method confirmed the resistance to antimi-
crobials shown by the disc diffusion method (vancomycin, 
teicoplanin, ampicillin, gentamicin, ciprofloxacin, line-
zolid, and tigecycline) (Tables 2, 3). A strain resistant to li-
nezolid and tigecycline was not reported among the tested 
enterococcal strains. All E. faecalis were also susceptible 
to ampicillin, vancomycin and teicoplanin. HLAR, HLGR 
and HLSR phenotypes were present in 33.3%, 20% and 
6.6% of E. faecalis strains, respectively. All enterococci 
from E. faecium species were also susceptible to quinu-
pristin-dalfopristin. Among all E. faecium isolates from 
hospitals C and D, resistance to ampicillin and vanco-
mycin was detected. A high percentage of E.  faecium 
(87.32%) presented HLAR phenotype, including 78.33% 
of strains from hospital C and 100% from D. Further-
more, in hospital D, HLSR (1.67%) and HLGR (10%) were 
detected in E. faecium. Also, very high rates of resistance 
to ciprofloxacin and 2 other fluoroquinolones (levofloxa-
cin and norfloxacin) were observed in hospitals C (98.3%) 
and D (96%). In our study, E. faecalis isolates were more 
susceptible to antimicrobials than E. faecium, which were 
largely multidrug-resistant. Detailed results are shown 
in Tables 2 and 3. In hospitals A and B, MDR was not 
reported among the tested Enterococcus strains. In hos-
pitals C and D, 95% and 96%, respectively, were classified 
as MDR strains.
Prevalence of resistance genes
In the study group there were 136 gentamicin resistance 
strains containing the aac(6’)-Ie-aph(2”)-Ia gene, which 
encodes the bifunctional enzyme AAC(6’)-APH(2”), and 
6 strains encoding the aph(2”)-Id gene that also mediates 
resistance to gentamicin. All 123 streptomycin resistance 
strains contained the aph(3’)-IIIa gene. 115 vanB genes 
and only 21 vanA genes were detected in enterococci. 
PCR analysis confirmed the phenotypic analysis.
Detection of virulence factor genes
Esp genes were detected in all E. faecium isolates and 
the  majority of  E. faecium isolates carried hyl (97%), 
in contrast to E. faecalis strains, in which different com-
binations of asa1, esp, gelE, and cylA genes were detected 
(Fig. 1).
Phenotypic analysis of virulence factors
In  hospitals A  and B, where E.  faecalis constituted 
the majority of the isolated strains, cytolysin as well as ge-
latinase were produced. 100% of the gene responsible for Ta
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producing cytolysin underwent expression. The activity 
of gelatinase was detected only for 5 strains that had all 
3 regulator genes ( fsrA, fsrB and fsrC) from 9 enterococci 
containing the gene encoding gelatinase. No DNase ac-
tivity was observed in any of the tested strains from all 
the hospitals (Table 4).
Detection of a specific mobile insertion 
element IS16
Molecular analysis of all analyzed E. faecium strains 
showed the presence of a gene fragment specific for IS16 
insertion element.
Discussion
In our study, the majority of patients were hospitalized 
in ICU, which is similar to other reports and seems to be 
an important risk factor for enterococci infections.19,20
Antimicrobial resistance
Our study confirms that E. faecalis is still a rare res-
ervoir of acquired vancomycin resistance, and this trend 
is well-known in our country and in Europe.2,21 The major-
ity of E. faecalis strains were susceptible to ampicillin and 
other antimicrobials, and it seems that E. faecalis species 
is not a therapeutic problem in hospitals in Małopolska.
The major determinant of vancomycin resistance among 
Polish VREfm is still the VanA gene cluster, which is also 
most prevalent in some European counties.2,19,22 How-
ever, in our study, E. faecium VanA phenotype strains 
were in  the  minority, while VanB phenotype isolates 
were in the majority. This seems to be the characteristic 
feature for VREfm from the Małopolska region, because 
in other provinces VanA phenotype is predominant.8,23,24 
In Małopolska, in recent years, the presence of both VanA 
and VanB phenotypes has been described.25–27 All VRE-
fm strains isolated in  this study were MDR and this 
is a problem for the therapeutic management of patients. 
The most important problem with the multidrug resis-
tance of the studied strains is that they are able to easily 
acquire (by plasmids and/or transposon transfer) new re-
sistance traits between enterococci.
In our research, we isolated only 1 strain which belonged 
to the E. avium species and included the HLAR pheno-
type but was susceptible to other antimicrobials. Therefore, 
it seems that other enterococcal species are not a threat 
to the therapeutic situation in the Małopolska region nowa-
days. In our study, only a few E. faecalis strains and a large 
group of E. faecium strains, including all VREfm isolates, 
were resistant to ampicillin. It  is a very disturbing and 
Table 4. Distribution of cytolysin (hemolysin), gelatinase and DNase 
activity in the genus Enterococcus isolates from hospitals A, B, C, and D
Hospital
Virulence determinants
cytolysin gelatinase DNase
A 1 2 0
B 2 3 0
C 0 0 0
D 0 0 0
Total 3 5 0
Fig. 1. Occurrence of virulence determinants asa1, gelE, cylA, esp and hyl in enterococci isolates from hospitals A, B, C, and D
D
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B
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gelE hyl esp cylA asa1
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dangerous situation, because β-lactam antibiotics are a vi-
tal group of drugs employed for the treatment of infections 
caused by enterococci. Ampicillin resistance also indicates 
resistance to amoxicillin, piperacillin and preparations com-
bined with β-lactamase (ampicillin/sulbactam, amoxicil-
lin/clavulanic acid, piperacillin/tazobactam).28 Moreover, 
it is well known that ampicillin-resistant E. faecium  are 
a precursor of multidrug-resistant strains, including VRE, 
and are widespread in Polish and European hospitals.2,19 
Enterococci are inherently resistant to  low concentra-
tions of aminoglycosides, which is associated with reduced 
permeability of these antibiotics through the cell wall.29 
In agreement with other studies from Poland, also ours, 
the spread of the aac(6’)-Ie-aph(2”)-Ia gene, which encodes 
the bifunctional enzyme AAC(6’)-APH(2”) and eliminates 
the synergistic effect between β-lactams or glycopeptide an-
tibiotics and aminoglycosides, was responsible for high-level 
resistance to gentamicin among the majority of enterococ-
ci.22,28 Thus, it precludes its therapeutic application in severe 
infections caused by enterococci, including bacteremia and 
endocarditis.28,29 If the strains are resistant to high con-
centrations of gentamicin with simultaneous sensitivity 
to streptomycin (HLGR), streptomycin can be used in com-
bination with β-lactams and glycopeptides. If the strains dis-
play HLSR phenotype, which means that they are resistant 
to high concentrations of streptomycin with simultaneous 
sensitivity to gentamicin, streptomycin therapy can be ap-
plied combined with β-lactams and glycopeptides, since 
the therapeutic effect is present. Detection of resistance 
to high concentrations of gentamicin and streptomycin 
at the same time (HLAR) means that there is no synergy 
of aminoglycosides with β-lactams and glycopeptides, which 
was found in a high degree in the strains examined by us.28,29 
For years, a tendency that has appeared among enterococci, 
also in Poland, regards their growing resistance to fluoroqui-
nolones. In hospital A, this regularity is poorly marked (only 
33.3% of resistant strains). In hospital B, it increases to ap-
prox. 50% of resistant strains, but it is best marked by a high 
resistance to ciprofloxacin, levofloxacin and norfloxacin 
in the enterococci investigated in hospitals C and D. This 
also proves that a very high percentage of resistant strains 
is common among the species E. faecium, which is also de-
scribed in other studies originating in Poland.19,28 Quinu-
pristin-dalfopristin (Q/D) (with the exception of the E. fae-
calis species), linezolid and tigecycline have bacteriostatic 
activity against VRE, so they are recommended for the treat-
ment of various infections caused by strains simultaneously 
resistant to several groups of antibiotics, such as ampicil-
lin, glycopeptides, and a high concentration of aminogly-
cosides. Our data suggests that these antimicrobials may 
be effective therapeutic options for the treatment of seri-
ous infections caused by the studied enterococci strains. 
Unfortunately, Q/D treatment has failures and adverse ef-
fects, whereas acquired resistance to linezolid has been ob-
served in enterococci, but this phenomenon is still rare and 
associated with the duration of previous linezolid therapy.3,6
Virulence factors
Enterococci displaying virulence factors are more like-
ly to cause an infection than the strains devoid of them. 
There are factors that facilitate colonization and those 
that facilitate the infection of previously colonized tis-
sue. The majority of VREfm strains from hospitals C and 
D both contained esp and hylEfm genes. Hyaluronidase 
(encoded by the hyl gene) contributes to the destruction 
of connective tissue and thus makes it easier for bacte-
ria to spread in an infected organism.15 The enterococcal 
surface protein Esp (encoded by esp) is associated with in-
creased virulence, colonization and persistence in the uri-
nary tract and biofilm formation.15,18 In hospitals A and B, 
the situation was more diverse, and gelE, asa1, esp, hylEfm, 
and cylA genes in different combinations were detected 
in the enterococcal isolates. Gelatinase (encoded by gelE) 
has the ability to hydrolyze collagen, gelatin and small 
peptides.15,18 Aggregation substance (encoded by asa1) fa-
cilitates the adhesion of enterococci to host cells, supports 
aggregation and facilitates the survival of bacteria in mac-
rophages. Cytolysin has bacteriocin activity and the ability 
to lyse certain eukaryotic erythrocytes and gram-positive 
bacterial cells.15,18 Among the studied enterococci, there 
were also strains which did not have virulence determi-
nants. Moreover, like other researchers, we did not find 
DNase activity in either E. faecalis, E. faecium or E. avium 
isolates.17 Therefore, it seems that this is not a virulence 
factor that occurs in enterococci.
The correlation between drug resistance 
and virulence genes
Nowadays, in European hospitals, the vancomycin-sus-
ceptible enterocci are replaced by high-level ampicillin and 
ciprofloxacin resistance, HLAR and VRE phenotype simul-
taneously, which are typical of hospital-acquired VREfm. 
The E. faecium strains examined in our study also shared 
other subpopulation characteristics of hospital-acquired 
strains, such as the presence of esp, hyl and IS16.18,30 Phe-
notypic and molecular characterization of the E. faecium 
isolates tested coming from hospitals C and D corresponds 
to the characteristics of strains with high epidemic po-
tential occurring in hospitals in Europe (Clonal Complex 
CC17). The specific mobile insertion element IS16 is highly 
specific for predicting hospital-associated strain types.30 
In our study, all strains belonging to the E. faecium spe-
cies showed the presence of IS16, which is a similar result 
to other studies from Poland.19,22,23,30
Conclusions
The E. faecalis strains that appear in Małopolska hospi-
tals are largely sensitive to antibiotics and have a variable 
amount of virulence factors. The E. faecalis species were 
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isolated less frequently than E. faecium from patients hos-
pitalized in Małopolska hospitals. In contrast, the strains 
of the species E. faecium are a more uniform group with 
resistance to a number of significant therapeutic drug 
types, such as ampicillin, high concentrations of amino-
glycosides, fluoroquinolones and glycopeptides (also more 
often displaying the VanB phenotype). VREfm strains also 
have a high proportion of hyl and esp genes, which is char-
acteristic of hospital strains of enterococci. 
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